Prevalence of hypothyroidism and Graves disease in sarcoidosis

Chest

Volumn 130, Issue 2, 2006, Pages 526-532

  Antonelli, Alessandro ^a   Fazzi, Piera ^a   Fallahi, Poupak ^a   Ferrari, Silvia Martina ^a   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Antithyroid peroxidase antibody; Autoimmune thyroiditis; Graves disease; Hypothyroidism; Sarcoidosis; Thyroid cancer; Thyroid ultrasonography

Indexed keywords

CORTICOSTEROID; IODINE; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; AGE; ARTICLE; ASPIRATION BIOPSY; BLOOD FLOW; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; GENDER; GRAVES DISEASE; HASHIMOTO DISEASE; HIGH RISK PATIENT; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SARCOIDOSIS; THYROID FUNCTION TEST;

EID: 33747595238     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.2.526     Document Type: Article

References (30)

1. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305:429-434
2. Hunninghake GW, Gadek JE, Young RC, et al. Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med 1980; 302:594-598
3. Fazzi P, Solfanelli S, Di Pede F, et al. Sarcoidosis in Tuscany: a preliminary report. Sarcoidosis 1992; 9:123-126
4. Fazzi P. Pharmacotherapeutic management of pulmonary sarcoidosis. Am J Respir Med 2003; 2:311-320
5. Rubinstein I, Baum GL, Hiss Y, et al. Sarcoidosis and Hashimoto's thyroiditis: a chance occurrence? Respiration 1985; 48:136-139
6. Papadopoulos KI, Hornblad Y, Liljebladh H, et al. High frequency of endocrine autoimmunity in patients with sarcoidosis. Eur J Endocrinol 1996; 134:331-336
7. Nakamura H, Genma R, Mikami T, et al. High incidence of positive autoantibodies against thyroid peroxidase and thyroglobulin in patients with sarcoidosis. Clin Endocrinol (Oxf) 1997; 46:467-472
8. Ilias I, Panoutsopoulos G, Batsakis C, et al. Thyroid function and autoimmunity in sarcoidosis: a case-control study. Croat Med J 1998; 39:404-406
9. Attali JR, Valensi P, Valeyre D, et al. Thyroid stimulating antibodies in sarcoidosis. Pathol Biol (Paris) 1994; 42:581-586
10. Heshmati HM, Cohen R, Modigliani E, et al. Hypothyroidism due to thyrotropin-receptor blocking antibodies associated with sarcoidosis. Ann Med Interne (Paris) 1997; 148:102-103
11. Hugues JN, Modigliani E, Battesti JP, et al. Thyroid disorders during sarcoidosis. Ann Med Interne (Paris) 1981; 132:367-371
12. Zimmermann-Belsing T, Christensen L, Hansen HS, et al. A case of sarcoidosis and sarcoid granuloma, papillary carcinoma, and Graves' disease in the thyroid gland. Thyroid 2000; 10:275-278
13. Yarman S, Kahraman H, Tanakol R, et al. Concomitant association of thyroid sarcoidosis and Graves' disease. Horm Res 2003; 59:43-46
14. Murialdo G, Tamagno G. Endocrine aspects of neurosarcoidosis. J Endocrinol Invest 2002; 25:650-662
15. Reynolds HY. Sarcoidosis: impact of other illnesses on the presentation and management of multi-organ disease. Lung 2002; 180:281-299
16. Vailati A, Marena C, Aristia L, et al. Sarcoidosis of the thyroid: report of a case and a review of the literature. Sarcoidosis 1993; 10:66-68
17. Bell NH. Endocrine complications of sarcoidosis. Endocrinol Metab Clin North Am 1991; 20:645-654
18. Chiovato L, Lapi P, Fiore E, et al. Thyroid autoimmunity and female gender. J Endocrinol Invest 1993; 16:384-391
19. Donati L, Antonelli A, Bertoni F, et al. Clinical picture of endemic cretinism in central Appennines (Montefeltro). Thyroid 1992; 2:283-290
20. Antonelli A, Ferri C, Pampana A, et al. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117:10-13
21. Antonelli A, Fallahi P, Nesti C, et al. Anti-CD38 autoimmunity in patients with chronic autoimmune thyroiditis or Graves' disease. Clin Exp Immunol 2001; 126:426-431
22. Antonelli A, Rotondi M, Fallahi P, et al. Increase of interferon-gamma inducible α chemokine CXC10 but not β chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 2005; 152:171-177
23. Antonelli A, Rotondi M, Fallahi P, et al. High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 2004; 89:5496-5499
24. Antonelli A, Ferri C, Fallahi P, et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. Q J Med 2004; 97:499-506
25. Vanderpump MP, Tunbridge WM. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002; 12:839-847
26. Romagnani S. The Th1/Th2 paradigm in disease. New York, NY: R.G. Landes Company, Austin/Springer-Verlag, 1997
27. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997; 18:263-266
28. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005; 60:565-582
29. Moller DR. Treatment of sarcoidosis: from a basic science point of view. J Intern Med 2003; 253:31-40
30. Antonelli A, Rotondi M, Ferrari SM, et al. Interferon-γ-inducible α-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-γ agonists. J Clin Endocrinol Metab 2006; 91:614-620